BPC-157 · TB-500 · GHK-Cu · KPV — Synergistic Recovery Protocol
A four-compound synergistic protocol combining tissue repair (BPC-157), systemic healing (TB-500), collagen synthesis (GHK-Cu) and anti-inflammatory immune modulation (KPV) into a comprehensive recovery and regeneration stack.
The KLOW Stack is a combination protocol using four peptide compounds selected for their complementary and synergistic mechanisms across tissue repair, inflammation control, collagen production and immune modulation. Rather than being a single compound, it represents a structured approach to comprehensive recovery support where each component addresses a different aspect of the healing process.
Body Protection Compound-157 is the primary tissue repair agent in the stack. A 15 amino acid peptide isolated from human gastric juice, it promotes tendon and ligament healing through fibroblast migration, growth factor upregulation and angiogenesis. It is particularly effective when injected near injury sites and has demonstrated healing without scar tissue formation in animal models. 36+ published studies support its regenerative properties.
Thymosin Beta-4 analogue provides the systemic dimension of the stack. Unlike BPC-157's primarily local effects, TB-500 distributes throughout the body, promoting cell migration and new blood vessel formation systemically. The BPC-157 + TB-500 combination has been studied together in knee pain research where 87.5% of patients reported significant relief — a higher response rate than either compound alone in comparable cohorts.
GHK-Cu (copper tripeptide glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring copper peptide found in human plasma, saliva and urine. It plays a fundamental role in wound healing and is one of the most studied peptides for collagen synthesis. Research demonstrates GHK-Cu activates collagen, elastin and glycosaminoglycan synthesis; promotes wound healing; has anti-inflammatory effects; and shows neurotrophic (nerve-supporting) properties. It can be administered SubQ or applied topically, with topical application showing effective tissue penetration for skin repair applications.
KPV is a tripeptide fragment of alpha-melanocyte stimulating hormone (α-MSH), specifically the C-terminal tripeptide Lys-Pro-Val. It acts as a potent anti-inflammatory agent through several mechanisms: inhibition of pro-inflammatory pathways including NF-κB; direct anti-inflammatory effects on immune cells including macrophages and T-cells; gut mucosal protection and reduction of intestinal inflammation; and immune homeostasis modulation. Its mechanism is distinct from the other stack components, providing anti-inflammatory coverage that creates an optimal environment for the repair processes the other compounds drive.
The combination addresses all major phases of tissue repair simultaneously: BPC-157 drives local cellular repair; TB-500 ensures systemic delivery of healing cells and vascular support; GHK-Cu provides the collagen substrate for structural tissue rebuilding; and KPV controls the inflammatory environment that can otherwise impede healing. Together they represent a more comprehensive approach than any single compound alone.